Il mercato degli anticorpi personalizzati è stato valutato a 833,71 milioni di dollari entro il 2028 rispetto a 409,26 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 10,7% dal 2021 al 2028.
È possibile generare anticorpi personalizzati in un topo, ratto o criceto per soddisfare qualsiasi ospite requisiti. Le aziende forniscono un'ampia gamma di anticorpi in base alle esigenze del ricercatore. Esistono una varietà di anticorpi personalizzati sul mercato che includono anticorpi policlonali e monoclonali, anticorpi monoclonali ricombinanti, anticorpi per ibridomi, anticorpi ricombinanti policlonali e altri. Le aziende offrono servizi di supporto completi per tutti i tipi e le fasi della produzione di anticorpi, dalla progettazione del peptide, sintesi e coniugazione delle proteine trasportatrici all'immunizzazione degli animali, raccolta del siero o fusione di ibridomi, analisi del titolo e purificazione finale degli anticorpi.
La crescita del mercato degli anticorpi personalizzati è attribuita a fattori quali l'elevata domanda nella ricerca, il crescente sostegno da parte dei governi, il continuo cambiamento delle malattie profili, l’aumento dei partenariati pubblico-privati e l’aumento delle attività di finanziamento stanno migliorando ampiamente le prestazioni della biotecnologia. Tuttavia, la produzione degli anticorpi monoclonali e policlonali varia in base agli animali utilizzati per ricavarli. Il costo è determinato anche dai pacchetti di anticorpi personalizzati richiesti per le diverse applicazioni offerti da diversi attori che ostacolano la crescita del mercato.
Regioni redditizie per il mercato degli anticorpi personalizzati
Approfondimenti di mercato
Servizi di produzione e sviluppo offerti da fornitori di anticorpi personalizzati
Varie aziende offrono in modo aggressivo servizi di ricerca e sviluppo per anticorpi personalizzati. Alcuni di questi servizi lanciati da queste società sono menzionati di seguito.
- Nel giugno 2021, GenScript ha annunciato il lancio del suo MonoRab, un servizio personalizzato di anticorpi monoclonali di coniglio (mAB). Viene aggiunto al portafoglio di servizi anticorpali premium integrati dell'azienda. MonoRab è la tecnologia proprietaria dell'azienda che utilizza la combinazione di tecnologie di ibridomi e sequenziamento di anticorpi monoclonali in fase iniziale. Entrambe le tecnologie forniscono mAb di coniglio personalizzati che sono più specifici e possiedono un'affinità più elevata, nonché capacità diversificate necessarie per un'ampia gamma di applicazioni.
- Nel marzo 2021 Giotto Biotech ha lanciato servizi specializzati di produzione di anticorpi policlonali e monoclonali. L’azienda facilita la produzione di oltre 500 tipi di anticorpi monoclonali che possono essere utilizzati per applicazioni diagnostiche e terapeutiche. Offre un'ampia scelta di specie come fonti di anticorpi policlonali.
- Nel novembre 2020, AMSBIO ha annunciato servizi di sviluppo per anticorpi monoclonali ricombinanti di coniglio e topo. Lo sviluppo di anticorpi monoclonali ricombinanti si basa sulla piattaforma di sviluppo DimAb, che è diversa dalle tradizionali tecnologie di fusione degli ibridomi. Ha la capacità di isolare i geni IgG dalle cellule B di animali immunizzati. Questi anticorpi aiutano nello sviluppo e nella commercializzazione di farmaci sul mercato. Nell'ottobre 2019, la FDA ha approvato il primo farmaco derivato da anticorpi monoclonali di coniglio, Beovu. Beovu è destinato al trattamento della degenerazione maculare umida legata all'età (AMD).
- Nel marzo 2020, Absolute Antibody Ltd ha annunciato il lancio del servizio di produzione di anticorpi ricombinanti ad alta produttività per il suo FleXpress. L'azienda offre ai propri clienti servizi per facilitare la rapida espressione di molti anticorpi, fino a un volume di 80 ml, nonché per potenziare la capacità di produzione per soddisfare la crescente domanda di tecnologia degli anticorpi ricombinanti.
Tali servizi di produzione di anticorpi personalizzati offerti dalle aziende stanno accelerando la crescita del mercato.
Approfondimenti basati sul servizio
Basati sul servizio , il mercato degli anticorpi personalizzati è segmentato in sviluppo di anticorpi, produzione e purificazione di anticorpi e frammentazione ed etichettatura di anticorpi. Nel 2020, il segmento dello sviluppo di anticorpi ha detenuto la quota maggiore del mercato e si stima che crescerà a un CAGR significativo durante il periodo di previsione.
Mercato degli anticorpi personalizzati, per servizio – 2020 e 2028
Approfondimenti basati sul tipo
In base al tipo, il mercato degli anticorpi personalizzati è segmentato in anticorpi monoclonali , anticorpi policlonali e altri anticorpi personalizzati. Nel 2020, il segmento degli anticorpi monoclonali ha detenuto la quota maggiore del mercato, mentre si prevede che il segmento degli anticorpi policlonali crescerà durante il periodo di previsione.
Approfondimenti basati sulla fonte< /p>
In base alla fonte, il mercato degli anticorpi personalizzati è segmentato in topi, conigli e altri. Il segmento dei topi ha detenuto la quota maggiore del mercato nel 2020, mentre si prevede che registrerà il CAGR più elevato del mercato durante il periodo di previsione.
Area di ricerca Approfondimenti basati su
In base all'area di ricerca, il mercato degli anticorpi personalizzati è segmentato in oncologia, immunologia, cellule staminali, malattie infettive, neurobiologia, malattie cardiovascolari e altri. Il segmento oncologico ha detenuto la quota maggiore del mercato nel 2020, mentre si prevede che il segmento delle cellule staminali registrerà il CAGR più elevato sul mercato durante il periodo di previsione.
Fine Approfondimenti basati sugli utenti
In base agli utenti finali, il mercato degli anticorpi personalizzati è segmentato in aziende farmaceutiche e biotecnologiche, istituti accademici e di ricerca e organizzazioni di ricerca a contratto. Nel 2020, il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota maggiore del mercato e si prevede che crescerà al ritmo più rapido nei prossimi anni.
Approfondimenti strategici
Il lancio e l'approvazione dei prodotti sono le strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti. Inoltre, gli attori del mercato della ricostruzione del seno si concentrano sulla strategia di collaborazione per ampliare la propria clientela, il che, a sua volta, consente loro di mantenere il proprio marchio a livello globale.
Per servizio< /h3>- Sviluppo di anticorpi
- Produzione e purificazione di anticorpi
- Frammentazione ed etichettatura di anticorpi
Per tipo
- Anticorpi monoclonali
- Anticorpi policlonali
- Altri anticorpi personalizzati
Per fonte
- Topi
- Conigli
- Altro
Per area di ricerca
- Oncologia
- Immunologia
- Cellule staminali
- Malattie infettive
- Neurobiologia
- Malattie cardiovascolari
- Altro
Da parte degli utenti finali
- Aziende farmaceutiche e biotecnologiche
- Istituti accademici e di ricerca
- Organizzazioni di ricerca a contratto
Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania
- Italia
- Regno Unito
- Spagna
< li>Resto d'Europa
- Stati Uniti
- Canada
- Messico
- Francia
- Germania
- Italia
- Regno Unito
- Spagna < li>Resto d'Europa
- Cina
- India
- Corea del Sud< /li>
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa
- Brasile
- Argentina
- Resto dell'America centrale e meridionale
Profili aziendali
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Customized antibodies can be generated in a mouse, rat or hamster, to meet any particular host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the market is attributed to some key driving factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. For instance, In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors. Such strategic steps are also projected to drive the market growth.
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the custom antibody market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology growth of Europe custom antibody market during the forecast period.
The List of Companies - Custom Antibody Market
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)